Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 2/3 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 5Lymphoma 4Neuroblastoma 3Lymphoma, Large B-Cell, Diffuse 3Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Disease 1Adenocarcinoma of Lung 1

Interventions

Rituximab 66Cyclophosphamide 46Vincristine 40Doxorubicin 40Prednisone 35Etoposide 19Radiotherapy 14Gemcitabine 13Peripheral Blood Stem Cell Transplantation 12Filgrastim 12Cytarabine 12Lenalidomide 11Carmustine 10VAP-cyclo protocol 9Prednisolone 9Oxaliplatin 9Melphalan 9Methotrexate 7Ifosfamide 7Mitoxantrone 6Bleomycin 6polatuzumab vedotin 5R-CHOP protocol 4Methylprednisolone 4Injections 4Granulocyte Colony-Stimulating Factor 4Cyclosporine 4Cisplatin 4Carboplatin 4pegfilgrastim 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Large B-Cell, Diffuse × Vindesine × Clear all
NCT02767674 2019-01-03

Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Unknown
258 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00135499 2018-08-23

R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma

Lymphoma Study Association

Phase 3 Terminated
138 enrolled
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT03018626 2017-07-28

R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL

Nanfang Hospital, Southern Medical University

Phase 3 Unknown
402 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡